Osimertinib for advanced non-small cell lung cancer...

Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI

Okuma, Yusuke, Hosomi, Yukio
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Journal of Thoracic Disease
DOI:
10.21037/jtd.2017.03.26
Date:
March, 2017
File:
PDF, 101 KB
english, 2017
Conversion to is in progress
Conversion to is failed